Brukinsa

Catalent CTS, LLC🇵🇭 Food and Drug Administration - Philippines

Approval Id: 3b9a9c32104d0f44
Drug Approval Philippines Name: Brukinsa
Product Name: Brukinsa
Registration Number: DR-XY48345
Brand Name: Brukinsa
Generic Name: Zanubrutinib
Dosage Form: Capsule
Dosage Strength: 80 mg
Manufacturer: Catalent CTS, LLC
Importer: Zuellig Pharma Corporation
Distributor: Zuellig Pharma Corporation
Company Detail Path: /organization/catalent-cts-llc-allendale-new-jersey-united-states
Issuance Date: 08 September 2022
Expiry Date: 08 September 2027
Pharmacologic Category: Bruton's Tyrosine Kinase (BTK) Inhibitor
Classification: Prescription Drug (RX)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

3b9a9c32104d0f44

Type

Standard